Biological Information

Background Information:


Why choose SafetyScreen18:
The SafetyScreen18 Functional Core Panel provides IC₅₀/EC₅₀ dose–response data across 18 high-priority targets strongly associated with clinical adverse effects, enabling very early de-risking.
The panel design is informed by current industry best practices reflecting meta-analysis of Top 20 pharma worldwide under the IQ DruSafe consortium (Brennan, R.J., et al. Nat Rev Drug Discov , 2024) to support safety margin calculations, allowing an anticipated and context-driven safety assessment


Key specs:
Testing conditions: Dose Response
Total assays: 26
Includes: P452-EU (23 assays) + P452-US (3 assays)
Checkout: Add P452-EU to your cart and P452-US is automatically added so your quote includes the full 26 assays covering 18 targets.
Kinases tested at 1mM ATP condition for more physiological relevance.


Where to find details:
See DOCUMENTS/REFERENCES (above) for the full assay list to be downloaded.
For P452-US assay details only, see RELATED SOLUTIONS (below).


Key Benefits
Cost-effective:
package
Coming Soon! Visualization and interpretation tool, In Vitro Safety Insight transform your screening data into contextualized safety insights by visualizing organ risks based on target activity, clinical exposure, and customizable safety margins for a more risk informed assessment (available in your online account).
Access data early: results released as they are validated.
Final report
delivered electronically with notification.


What’s next:
In order to get a complete safety assessment and for IND-submission, SatetyScreen59 (P458) needs to be performed in cascade after SafetyScreen18 to reach the 77 latest recommended targets by the industry.

No. of Assays on Panel:

23

Assays on Panel:

Family

GPCR

Name

Item

1243

Protein

M3

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1244

Protein

M3

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1392

Protein

mu (MOP)

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1393

Protein

mu (MOP)

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1500

Protein

alpha1A

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1501

Protein

alpha1A

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1685

Protein

D1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1686

Protein

D1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1744

Protein

CB1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1745

Protein

CB1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1976

Protein

beta2

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

1977

Protein

beta2

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

2542

Protein

H1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

2543

Protein

H1

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

3344

Protein

5-HT2B

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

3345

Protein

5-HT2B

Organism

Human

Assay Sub Type

Cell Based

Family

Enzyme

Name

Item

363

Protein

AChE

Organism

Human

Assay Sub Type

Enzymatic

Family

Enzyme

Name

Item

4072

Protein

PDE3A

Organism

Human

Assay Sub Type

Enzymatic

Family

Enzyme

Name

Item

4077

Protein

PDE4D

Organism

Human

Assay Sub Type

Enzymatic

Family

Transporter

Name

Item

4661

Protein

NET

Organism

Human

Assay Sub Type

Cell Based

Family

Transporter

Name

Item

4865

Protein

DAT

Organism

Human

Assay Sub Type

Cell Based

Family

Kinase

Name

Item

5911

Protein

Lck

Organism

Human

Assay Sub Type

Enzymatic

Family

Ion Channel

Name

Item

5921

Protein

KV11.1

Organism

Human

Assay Sub Type

Cell Based

Testing Information

Test Sample Requirements:

490 µL of a 333× DMSO stock solution, calculated from the top concentration to be tested (PBS working solutions are not compatible)

Turnaround Time

Standard:

20 Business Days

Service Scheduling Note:

Fixed monthly study start dates
See DOCUMENTS/REFERENCES (above) for compound receipt deadlines, study start dates, results delivery dates, and final report dates.
Compounds must be received by the stated deadline to be included in a given session
(late receipts are automatically scheduled for the next available session)
Results published online in your personal account on a rolling basis as tests are validated
Final reports delivered electronically, with email notification upon posting.

Additional Information

Brand:

SafetyScreen

Testing Location:

France - Celle L'Evescault

Other Information:


Available on demand in single-concentration screening format. Contact us for more information : ClientServicesPoitiers@discovery.eurofinseu.com
Please see Related Solutions below for more panels formats.

RELATED SOLUTIONS

Item: CYL8004QB2DR
Item: CYL7051QB2DR
Item: P447
Item: P448
Item: P456
Item: P458-EU
Item: P460-EU